MindWalk Holdings Corp. ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today announced an application of its proprietary HYFT® technology designed to ...

Detailed price information for Therapeutics Inc (MGX-Q) from The Globe and Mail including charting and trades.

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Amplia finished the December 2025 quarter with a cash position of $31.5 million (September 2025: $29.2 million). During the quarter, the Company had net operating cash inflows of $2.4 million in ...

Key Highlights from the Quarter ACCENT Trial Success: The ACCENT trial, testing narmafotinib with gemcitabine and Abraxane®, continues to demonstrate ...

Background Aortic valve calcification (AVC) is a disease process driven by inflammation and lipid infiltration, serving as a ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced positive topline three-year functional results from Part 1-treated patients in EMBARK (Study ...

The Central Board of Secondary Education (CBSE) has officially released the Class 12 Admit Card 2026 for students appearing ...

BSEB Class 12 exams will be held from February 2 to February 13, 2026. Practical exams are scheduled from January 10 to January 20, 2026. Date Sheet Released for Science, Commerce and Humanities ...

Scientists at Google DeepMind —the company’s artificial intelligence research arm—say they’ve created an A.I. tool that can ...

The power of artificial intelligence (AI) and advanced computing has made it possible to design genetic sequences encoding ...

The upgrade follows recent developments at Sentynl Therapeutics, a subsidiary of Zydus Lifesciences, which secured U.S. FDA ...